Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
8h agoDelivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
9h agoRefers to Item 7 on the agenda: Report on the audit of the consolidated financial statements of Grupa Kęty SA
11h agoThe 4th BOCHK Science and Technology Innovation Prize Award Ceremony Concludes with Great Success
18h agoBuffalo Potash Files Annual Information Form and New Technical Report
19h agoIonik Announces 30-Day Extension of Senior Debt Facility
Viking Therapeutics, Inc. logo

Viking Therapeutics, Inc.

About

30.89USD+0.21 +0.68%
Closed • Updated at 22:10 GMT+00:00
Market Cap$3.59B
Volume1.22M
Beta1.12
RSI46.98
Health TechnologyPharmaceuticals: Major

Viking Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

May 5 2026
Viking Therapeutics Announces Two Poster Presentations at European Congress on Obesity (ECO) 2026
Apr 29 2026
Viking Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
Apr 22 2026
Viking Therapeutics to Report Financial Results for First Quarter 2026 on April 29, 2026
Mar 26 2026
Viking Therapeutics Announces Completion of Enrollment in Phase 3 VANQUISH-2 Trial of VK2735
Feb 11 2026
Viking Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Corporate Update

Community Chat

Ask AI

Try asking
6ix6ixAIEvents